ShotSpotter to Present at the 21st Annual Needham Growth Conference on January 16, 2019
NEWARK, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) — ShotSpotter, Inc. (NASDAQ: SSTI), the leader in gunshot detection solutions that help […]
Solid Biosciences to Present at the J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (NASDAQ: SLDB) today announced that Ilan Ganot, Co-Founder, Chief […]
TSX News -
Aura Completes Share Consolidation
ROAD TOWN, British Virgin Islands, Jan. 02, 2019 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) completed, effective December 31, […]
Ceapro Inc. to Present at Biotech Showcase™ 2019
Presentation with live audio webcast Tuesday, January 8, 2019 at 2:00 PM PST EDMONTON, Alberta, Jan. 02, 2019 (GLOBE NEWSWIRE) […]
Inovalon to Present at 37th Annual J.P. Morgan Healthcare Conference
BOWIE, Md., Jan. 02, 2019 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering […]
Independent Bank Group, Inc. Completes Acquisition of Guaranty Bancorp
MCKINNEY, Texas, Jan. 02, 2019 (GLOBE NEWSWIRE) — Independent Bank Group, Inc. (NASDAQ: IBTX), the holding company for Independent Bank, […]
Watsco Boosts Dividends 10% to $6.40 Per Share, Extends Payout Streak to 45 Years
MIAMI, Jan. 02, 2019 (GLOBE NEWSWIRE) — Watsco, Inc.’s (NYSE: WSO) Board of Directors approved a 10% increase in the […]
Spark Therapeutics to Participate in J.P. Morgan Healthcare Conference
PHILADELPHIA, Jan. 02, 2019 (GLOBE NEWSWIRE) — Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to […]
Stemline Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (NASDAQ:STML), a biopharmaceutical company focused on the development and […]
Onconova Submits Special Protocol Assessment (SPA) to FDA for Phase 3 Trial of Oral Rigosertib in Combination with Azacitidine (Vidaza®) for First-Line Myelodysplastic Syndromes (MDS)
SPA submitted to the FDA before year-end 2018, marking achievement of a key regulatory milestone Advancement of this Phase 3 […]
